Search Results (52)

Background/Objectives: Cu(II) complexes with polypyridine ligands have shown carcinogenic activity already described in the literature and appear as a possible alternative to cisplatin, which has several side effects. In view of this, four Cu(II) complexes with the formulas [Cu(L1)(H₂O)₂](PF₆)₂ (A1) and [Cu(L2)(H₂O)₂](PF₆)₂ (A2), [Cu(L1)(bipy)](PF₆)₂ (B1) and [Cu(L2)(bipy)](PF₆)₂ (B2) were synthesized, where L1 = dipyrido[1,2,5]oxadiazolo[3,4-b]quinoxaline, L2 = 6,7-dicyanodipyrido[2,2-d:2,3-f]quinoxaline, and bipy = 2,2′-bipyridine. Methods: The proposed structures supported characterization techniques (molar conductivity, elemental analyses, absorption spectroscopy in the infrared region, and UV–vis). The interaction of the complexes with DNA was evaluated through an ethidium bromide displacement assay, complemented by theoretical studies using molecular docking. Additionally, the cytotoxic activity of the complexes was tested against DU 145 (prostate tumor), MCF-7 (breast tumor), and PNT-2 (non-tumor prostate) cell lines, with all complexes showing promising results. Results: Among them, complex B1 exhibited the highest number of DNA contacts in molecular docking studies, a binding constant of 3.7 × 10⁶ in the ethidium bromide displacement assay. It was the most selective complex (IS = 5.43) for the DU 145 (prostate tumor) cell line, demonstrating greater selectivity than cisplatin. Conclusions: This study has demonstrated the potential of the Cu(II) complexes obtained, which could be an alternative to platinum complexes in the future Full article

Water conductivity sensing relies universally on electrical measurements, which are subject to corrosion of the electrodes and subsequent signal drift in prolonged in situ uses. Furthermore, they cannot provide contactless sensing or remote readout. To this end, a novel device for water conductivity monitoring has been developed by employing a microenvironment-sensitive ruthenium complex, [Ru(2,2′-bipyridine-4,4′-disulfonato)₃]⁴⁻, embedded into a quaternary ammonium functionalized cross-linked polymer support. The degree of swelling of the latter, which leads to a change in the emission lifetime, depends on the water conductivity. The sensor displays a reversible response (2 min ≤ t₉₀ ≤ 3 min) and has been shown to be stable for >65 h of continuous monitoring of 0.8–12.8 mS cm⁻¹ KCl solutions. Changes to the cation do not affect the sensor response, while changes to the anion type induce small effects. Variations in the dissolved O₂ or temperature require corrections of the response. The sensor can be interrogated alongside dissolved O₂ and pH luminescent sensors based on the same family of indicator dyes to exploit the definite advantages of luminescence lifetime-based detection. Full article

Antimony (Sb) is currently a widespread element with key roles in telecommunication, sustainable energy, and military industries, among others. Its significant toxicity determines the need to realize sensors for water, air, and soil and the industrial process monitoring of Sb species. Unfortunately, no antimony sensors exist so far, and just laboratory analysis methods are in use. We aimed to contribute to the development of optical sensors for the metalloid by tailoring, for the first time, luminescent Ru(II) and Re(I) polypyridyl complexes to probe and quantify the presence of Sb(III). The molecular design of the complexes includes the multifunctional Sb-binding 2-(2,2′-bithien-5-yl)-1H-imidazo[4,5-f]-1,10-phenanthroline (btip) ligand that ensures the molecular binding of Sb(III) in organic media. The Ru(II)-btip complex is additionally endowed with one 2,2′-bipyrazine (bpz) or two 1,4,5,8-tetraazaphenanthrene (tap) ligands, namely [Ru(bpz)(btip)₂]²⁺ and [Ru(tap)₂(btip)]²⁺, that boost the excited state oxidation potential of the probe, leading to an intramolecular photoinduced electron transfer from btip to the Ru(II) core. The latter is suppressed upon interaction with Sb(III), leading to an 11-fold increase in both the luminescence intensity and lifetime of [Ru(bpz)(btip)₂]²⁺ in the presence of ca. 50 μmol L⁻¹ of SbCl₃ in organic medium. The fluorescence intensity of [Re(CO)₃(H₂O)(btip)]⁺ also increases upon interaction with Sb(III) but to a much lesser extent due to the intraligand π*→π nature of its emission compared to the Ru(II) ligand-to-metal excited state deactivation. However, the weak π*→d emission band in the red spectral region of the former is quenched by the semimetallic element. The sensing mechanisms of the Ru(II)- and Re(I)-btip probes that allow luminescence intensity (Ru, Re), ratiometric (Ru), and lifetime measurements (Ru) are compared and discussed in this initial solution sensing study. Full article

Ruthenium(II) polypyridyl complexes are being tested as potential anticancer agents in different therapies, which include conventional chemotherapy and light-activated approaches. A mechanistic study on a recently synthesized dual-action Ru(II) complex [Ru(bpy)₂(sora)Cl]⁺ is described here. It is characterized by two mono-dentate leaving ligands, namely, chloride and sorafenib ligands, which make it possible to form a di-aquo complex able to bind DNA. At the same time, while the released sorafenib can induce ferroptosis, the complex is also able to act as a photosensitizer according to type II photodynamic therapy processes, thus generating one of the most harmful cytotoxic species, ¹O₂. In order to clarify the mechanism of action of the drug, computational strategies based on density functional theory are exploited. The photophysical properties of the complex, which include the absorption spectrum, the kinetics of ISC, and the character of all the excited states potentially involved in ¹O₂ generation, as well as the pathway providing the di-aquo complex, are fully explored. Interestingly, the outcomes show that light is needed to form the mono–aquo complex, after releasing both chloride and sorafenib ligands, while the second solvent molecule enters the coordination sphere of the metal once the system has come back to the ground-state potential energy surface. In order to simulate the interaction with canonical DNA, the di-aquo complex interaction with a guanine nucleobase as a model has also been studied. The whole study aims to elucidate the intricate details of the photodissociation process, which could help with designing tailored metal complexes as potential anticancer agents. Full article

Organometallic ruthenium complexes with p-cymene = 1-methyl-4-(1-methylethyl)-benzene and N^N = bidentate polypyridyl ligands constitute interesting candidates with biological and catalytic properties. Towards this aim, we have synthesized four ruthenium(II)–arene complexes of the type [Ru(η⁶-p-cymene)(N^N)Cl][X] (N^N = Br-Qpy = 6-bromo-4-phenyl-2-pyridin-2-yl-quinoline, X = Cl⁻ (1a); PF₆⁻ (1b); N^N = OH-Ph-Qpy = 4-(4-phenyl-2-(pyridin-2-yl)quinolin-6-yl)phenol, X = Cl⁻ (2a); PF₆⁻ (2b)). This is the first report of ruthenium(II) p-cymene complexes incorporating substituted pyridine–quinoline ligands, with –Br and –C₆H₄OH groups in the 6-position of quinoline. We also refer to the cytotoxicity of the ligands and their possible effect of modulating the activity of the ruthenium(II) complexes. These were characterized by a combination of spectroscopic methods (ATR-IR, UV–Vis, multinuclear NMR), elemental analysis, and conductivity measurements. The solid-state structure of 2b, determined by single-crystal X-ray diffraction, reveals a three-legged piano-stool geometry. The in vitro cytotoxic activities of the new complexes were evaluated in HEK293T (human embryonic kidney cells) and in HeLa cells (cervical cancer cells), via the MTT assay. Poor in vitro anticancer activities were observed for the HeLa cancer cell line, with 2a being the most potent (IC₅₀ = 75 μΜ). The cytotoxicity of Br-Qpy in HEK293T is comparable to that of cisplatin. Both complexes 1a and 1b successfully catalyze the transfer hydrogenation of benzophenone to benzhydrol by 2-propanol at 82 °C. The catalytic performance of 1a in the ratio of S:Cat:B = 400:1:40 (S = substrate, Cat = catalyst, B = base = KOiPr) leads to a conversion of 94%, within 3 h of reaction. Presumably, catalytic transformation takes place via ruthenium(II) hydride species being the active catalyst. Full article

Metal-containing compounds are an important class of chemotherapeutics used to treat various manifestations of cancer. Despite the widespread clinical use and success of metallopharmaceuticals, they are ineffective towards a sub-population of tumours called cancer stem cells (CSCs). CSCs evade current chemotherapeutic regimens (including metallopharmaceuticals) and promote cancer relapse and metastasis. Here, we report the synthesis, characterisation and anti-breast CSCs properties of a series of cobalt(III)-polypyridyl complexes with salicylic acid. The lead cobalt(III) complex 6 (containing 3,4,7,8-tetramethyl-1,10-phenanthroline) displayed low micromolar potency towards breast CSCs, significantly lower than the gold-standard anti-breast CSC agent, salinomycin, and the clinically used metallodrug, cisplatin. Mechanistic studies indicate that the cobalt(III) complex 6 induces its anti-breast CSC effect by entering breast CSCs, penetrating the nuclei, damaging nuclear DNA and triggering caspase-dependent apoptosis. The cytotoxic mechanism of action of the cobalt(III) complex 6 is also dependent on the modulation of cyclooxygenase-2 (COX-2) expression. This work highlights the anti-breast CSC properties of cobalt(III) coordination complexes with non-steroidal anti-inflammatory drugs (NSAIDs) and more widely spotlights the importance of metallopharmaceuticals in the development of new anticancer agents that can tackle chemotherapeutic-resistant sub-populations. Full article

Organometallic complexes of the formula [Ru(N^N)(p-cymene)Cl][X] (N^N = bidentate polypyridyl ligands, p-cymene = 1-methyl-4-(1-methylethyl)-benzene, X = counter anion), are currently studied as possible candidates for the potential treatment of cancer. Searching for new organometallic compounds with good to moderate cytotoxic activities, a series of mononuclear water-soluble ruthenium(II)–arene complexes incorporating substituted pyridine–quinoline ligands, with pending -CH₂OH, -CO₂H and -CO₂Me groups in the 4-position of quinoline ring, were synthesized, for the first time, to study their possible effect to modulate the activity of the ruthenium p-cymene complexes. These include the [Ru(η⁶-p-cymene)(pqhyme)Cl][X] (X = Cl⁻ (1-Cl), PF₆⁻ (1-PF₆), pqhyme = 4-hydroxymethyl-2-(pyridin-2-yl)quinoline), [Ru(η⁶-p-cymene)(pqca)Cl][Cl] ((2-Cl), pqca = 4-carboxy-2-(pyridin-2-yl)quinoline), and [Ru(η⁶-p-cymene)(pqcame)Cl][X] (X = Cl⁻ (3-Cl), PF₆⁻ (3-PF₆), pqcame = 4-carboxymethyl-2-(pyridin-2-yl)quinoline) complexes, respectively. Identification of the complexes was based on multinuclear NMR and ATR-IR spectroscopic methods, elemental analysis, conductivity measurements, UV–Vis spectroscopic, and ESI-HRMS techniques. The solid-state structures of 1-PF₆ and 3-PF₆ have been elucidated by single-crystal X-ray diffraction revealing a three-legged piano stool geometry. This is the first time that the in vitro cytotoxic activities of these complexes are studied. These were conducted in HEK293T (human embryonic kidney cells) and HeLa cells (cervical cancer cells) via the MTT assay. The results show poor in vitro anticancer activities for the HeLa cancer cell lines and 3-Cl proved to be the most potent (IC₅₀ > 80 μΜ). In both cell lines, the cytotoxicity of the ligand precursor pqhyme is significantly higher than that of cisplatin. Full article

Non-aqueous redox flow batteries (NARFBs) have been attracting much attention because they can significantly increase power and energy density compared to conventional RFBs. In this study, novel pore-filled anion-exchange membranes (PFAEMs) for application to a NAPFB employing metal polypyridyl complexes (i.e., Fe(bpy)₃²⁺/Fe(bpy)₃³⁺ and Co(bpy)₃²⁺/Co(bpy)₃³⁺) as the redox species are successfully developed. A porous polyethylene support with excellent solvent resistance and mechanical strength is used for membrane fabrication. The PFAEMs are prepared by filling an ionic liquid monomer containing an imidazolium group and a crosslinking agent into the pores of the support film and then performing in situ photopolymerization. As a result, the prepared membranes exhibit excellent mechanical strength and stability in a non-aqueous medium as well as high ion conductivity. In addition, a low crossover rate for redox ion species is observed for the prepared membranes because they have relatively low swelling characteristics in non-aqueous electrolyte solutions and low affinity for the metal-complex redox species compared to a commercial membrane. Consequently, the PFAEM is revealed to possess superior battery performance than a commercial membrane in the NARFB tests, showing high energy efficiency of about 85% and stable operation for 100 cycles. Full article

Poor responses to medical care and the failure of pharmacological treatment for many high-frequency diseases, such as cancer and viral infections, have been widely documented. In this context, numerous metal-based substances, including cisplatin, auranofin, various gold metallodrugs, and ruthenium complexes, are under study as possible anticancer and antiviral agents. The two Ru(III) and Ru(II) complexes, namely, BOLD-100 and RAPTA-C, are presently being studied in a clinical trial and preclinical studies evaluation, respectively, as anticancer agents. Interestingly, BOLD-100 has also recently demonstrated antiviral activity against SARS-CoV-2, which is the virus responsible for the COVID-19 pandemic. Over the last years, much effort has been dedicated to discovering new dual anticancer–antiviral agents. Ru-based complexes could be very suitable in this respect. Thus, this review focuses on the most recent studies regarding newly synthesized Ru(II) complexes for use as anticancer and/or antiviral agents. Full article

We report the DNA-binding properties of three porphyrins with peripheral thienyl substituents (TThPor, PdTThPor and PtTThPor). The binding capacity of each porphyrin with DNA was determined by UV-Vis and steady-state fluorescence emission spectroscopy combined with molecular docking calculations. The results suggest that the interaction of these compounds probably occurs via secondary interactions via external grooves (minor grooves) around the DNA macromolecule. Moreover, porphyrins containing peripheral Pd(II) or Pt(II) complexes (PdTThPor and PtTThPor) were able to promote photo-damage in the DNA. Full article

Ruthenium (Ru)-based organometallic drugs have gained attention as chemotherapeutic and bioimaging agents due to their fewer side effects and excellent physical optical properties. Tuning the electronic structures of Ru complexes has been proven to increase the cytotoxicity of cancer cells and the luminescent efficiency of the analytical probes. However, the relationship between electronic structures and bioactivities is still unclear due to the potential enhancement of both electron donor and acceptor properties. Thus, we investigated the relationship between the electronic structures of Ru(II) complexes and cytotoxicity by optimizing the electron-withdrawing (complex 1), electron-neutral (complex 2), and electron-donating (complex 3) ligands through DFT calculations, bioactivities tests, and docking studies. Our results indicated that it was not sufficient to consider only either the effect of electron-withdrawing or electron-donating effects on biological activities instead of the total electronic effects. Furthermore, these complexes with electron-donating substituents (complex 3) featured unique “off-on” luminescent emission phenomena caused by the various “HOMO-LUMO” distributions when they interacted with DNA, while complex with electron-withdrawing substituent showed an “always-on” signature. These findings offer valuable insight into the development of bifunctional chemotherapeutic agents along with bioimaging ability. Full article

Over the years, Ru^IV(bpy)₂(py)(O)²⁺([Ru^IVO]²⁺) has garnered considerable interest owing to its extensive use as a polypyridine mono-oxygen complex. However, as the active-site Ru=O bond changes during the oxidation process, [Ru^IVO]²⁺ can be used to simulate the reactions of various high-priced metallic oxides. In order to elucidate the hydrogen element transfer process between the Ruthenium-oxo-polypyridyl complex and organic hydride donor, the current study reports on the synthesis of [Ru^IVO]²⁺, a polypyridine mono-oxygen complex, in addition to 1H and 3H (organic hydride compounds) and 1H derivative: 2. Through ¹H-NMR analysis and thermodynamics- and kinetics-based assessments, we collected data on [Ru^IVO]²⁺ and two organic hydride donors and their corresponding intermediates and established a thermodynamic platform. It was confirmed that a one-step hydride transfer reaction between [Ru^IVO]²⁺ and these organic hydride donors occurs, and here, the advantages and nature of the new mechanism approach are revealed. Accordingly, these findings can considerably contribute to the better application of the compound in theoretical research and organic synthesis. Full article

Cancer poses a significant threat to global health and new treatments are required to improve the prognosis for patients. Previously, unconventional platinum complexes designed to incorporate polypyridyl ligands paired with diaminocyclohexane have demonstrated anticancer activity in KRAS mutated cells, previously thought to be undruggable and have cytotoxicity values up to 100 times better than cisplatin. In this work, these complexes were used as inspiration to design six novel cyclometallated examples, whose fluorescence could be exploited to better understand the mechanism of action of these kinds of platinum drugs. The cytotoxicity results revealed that these cyclometallated complexes (CMCs) have significantly different activity compared to the complexes that inspired them; they are as cytotoxic as cisplatin and have much higher selectivity indices in breast cancer cell lines (MCF10A/MCF-7). Complexes 1b, 2a, and 3b all had very high selectivity indexes compared to previous Pt(II) complexes. This prompted further investigation into their DNA binding properties, which revealed that they had good affinity to ctDNA, especially CMCs 1a and 3b. Their inherent fluorescence was successfully utilised in the calculation of their DNA binding affinity and could be useful in future work. Full article

We synthesized the luminescent ruthenium(II) polypyridyl complexes of type [Ru(bpy)₂(L1)][ClO₄]₂ (1) (where L1 = 4,4-dicarboxy-2,2-bipyridine); [Ru(bpy)₂(L2)][ClO₄]₂ (2); and [Ru(L2)₃][ClO₄]₂ (3) (where L2 = 4,4-dimethanol-2,2-bipyridine). Photo-physical and electrochemical properties of the Ru(II) complexes were investigated along with the emission vs. pH. This reveals that the carboxylic acids in the 2,2-bipyridine ligand had a more important influence on the photophysical and electrochemical properties of the Ru(II) complexes than alcohol. The crystal structure of the Ru(II) complexes 1–3 is also discussed in this paper. The cyclic voltammetry of 1–3 yields a reversible RuIII/II wave that shifts 1.4–1.2 V. UV/Visible absorbance spectroscopy reveals that Metal-to-Ligand Charge Transfer (MLCT) transitions shift to lower energy upon deprotonation of the complex. Full article

The collection of solar energy in chemical bonds via dye-sensitized photoelectrosynthesis cells (DSPECs) is a reliable solution. Herein, atomic layer deposition (ALD) introduced ultrathin blocking layers (BLs) between a mesoporous TiO₂ membrane and fluorine-doped tin oxide (FTO), and much improved photoelectrochemical water oxidation performance was well documented. Samples with different BL thicknesses deposited on FTO were obtained by ALD. In the photoanode, polypyridyl Ru(II) complexes were used as photosensitizers, and Ru(bda)-type was used as a catalyst during water oxidation. Under one sun irradiation, the BL (i) increased the photocurrent density; (ii) slowed down the open-circuit voltage decay (OCVD) by electrochemical measurement; (iii) increased the photo-generated electron lifetime roughly from 1 s to more than 100 s; and (iv) enhanced the water oxidation efficiency from 25% to 85% with 0.4 V of applied voltage bias. All this pointed out that the ALD technique-prepared layers could greatly hinder the photogenerated electron–hole pair recombination in the TiO₂-based photoanode. This study offers critical backing for the building of molecular films by the ALD technique to split water effectively. Full article